Neuroscience

SARS-CoV-2 vaccine does not increase new-onset seizure risk

There is no risk for new-onset seizure incidence for individuals receiving a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine versus placebo, according to a review published online April 29 in JAMA Neurology.

Immunology

Protein responsible for genetic inflammatory disease identified

A team of researchers led by Dr. Hirotsugu Oda at the University of Cologne's CECAD Cluster of Excellence for Aging Research has discovered the role a specific protein complex plays in certain forms of immune dysregulation. ...

Immunology

How the immune system learns from harmless particles

Our lungs are bombarded by all manner of different particles every single day. While some are perfectly safe for us, others—known as pathogens—have the potential to make us ill. The immune system trains its response whenever ...

Diseases, Conditions, Syndromes

Study confirms effectiveness of bivalent COVID-19 vaccine

A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less abundantly, according to ...

page 2 from 40